Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Sept 18 (Reuters) — SANDOZ GROUP AG: Sandoz Announces Collaboration With Mabxience To Expand Patient Access To Life-enhancing Biosimilar Medicines Agrees Emicizumab Biosimilar In $5.70 Billion Market; First Haemophilia Biosimilar In Pipeline Biosimilar Pipeline Expands To 40 Assets Following Agreement With Mabxience So
Sandoz Group AG / Key word(s): Agreement Sandoz announces collaboration with mAbxience to expand patient access to life-enhancing biosimilar medicines 18.09.2026 / 07:15 CET/CEST ══════════════════════════════════════════════════════════════════════════════════════════════════════ Media Release • Agreement for emicizum